Treatment interruption in chronic HIV-1 infection: does it deliver?

PURPOSE OF REVIEW: This review sets out to overview treatment interruption in chronic HIV-1 infection: what treatment interruption promised, results from recent trials, and what the future holds. RECENT FINDINGS: Recent studies have produced mixed results; several trials have been prematurely halte...

Full description

Bibliographic Details
Main Authors: Willberg, C, Nixon, D
Format: Journal article
Language:English
Published: 2007
_version_ 1797051912255700992
author Willberg, C
Nixon, D
author_facet Willberg, C
Nixon, D
author_sort Willberg, C
collection OXFORD
description PURPOSE OF REVIEW: This review sets out to overview treatment interruption in chronic HIV-1 infection: what treatment interruption promised, results from recent trials, and what the future holds. RECENT FINDINGS: Recent studies have produced mixed results; several trials have been prematurely halted, whereas others have reported more positive outcomes. One consistent finding has been the identification of the CD4 T-cell count nadir as a critical parameter in determining the outcome of treatment interruption. SUMMARY: The use of treatment interruption is still controversial, but it is becoming clear that certain individuals could benefit, and partial treatment interruption strategies warrant further investigation.
first_indexed 2024-03-06T18:25:56Z
format Journal article
id oxford-uuid:07f7100a-b683-47c8-8f7c-ce08227871d0
institution University of Oxford
language English
last_indexed 2024-03-06T18:25:56Z
publishDate 2007
record_format dspace
spelling oxford-uuid:07f7100a-b683-47c8-8f7c-ce08227871d02022-03-26T09:10:25ZTreatment interruption in chronic HIV-1 infection: does it deliver?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:07f7100a-b683-47c8-8f7c-ce08227871d0EnglishSymplectic Elements at Oxford2007Willberg, CNixon, D PURPOSE OF REVIEW: This review sets out to overview treatment interruption in chronic HIV-1 infection: what treatment interruption promised, results from recent trials, and what the future holds. RECENT FINDINGS: Recent studies have produced mixed results; several trials have been prematurely halted, whereas others have reported more positive outcomes. One consistent finding has been the identification of the CD4 T-cell count nadir as a critical parameter in determining the outcome of treatment interruption. SUMMARY: The use of treatment interruption is still controversial, but it is becoming clear that certain individuals could benefit, and partial treatment interruption strategies warrant further investigation.
spellingShingle Willberg, C
Nixon, D
Treatment interruption in chronic HIV-1 infection: does it deliver?
title Treatment interruption in chronic HIV-1 infection: does it deliver?
title_full Treatment interruption in chronic HIV-1 infection: does it deliver?
title_fullStr Treatment interruption in chronic HIV-1 infection: does it deliver?
title_full_unstemmed Treatment interruption in chronic HIV-1 infection: does it deliver?
title_short Treatment interruption in chronic HIV-1 infection: does it deliver?
title_sort treatment interruption in chronic hiv 1 infection does it deliver
work_keys_str_mv AT willbergc treatmentinterruptioninchronichiv1infectiondoesitdeliver
AT nixond treatmentinterruptioninchronichiv1infectiondoesitdeliver